- Home
- CRNT vs DERM Comparison
CRNT vs DERM Comparison
Compare CRNT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- DERM
- Stock Information
- Founded
- CRNT 1996
- DERM 2014
- Country
- CRNT Israel
- DERM United States
- Employees
- CRNT N/A
- DERM N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- DERM Health Care
- Exchange
- CRNT Nasdaq
- DERM Nasdaq
- Market Cap
- CRNT 218.8M
- DERM 181.0M
- IPO Year
- CRNT 2000
- DERM 2021
- Fundamental
- Price
- CRNT $2.45
- DERM $7.15
- Analyst Decision
- CRNT Strong Buy
- DERM Strong Buy
- Analyst Count
- CRNT 5
- DERM 1
- Target Price
- CRNT $5.85
- DERM $9.00
- AVG Volume (30 Days)
- CRNT 728.3K
- DERM 179.1K
- Earning Date
- CRNT 08-06-2025
- DERM 08-11-2025
- Dividend Yield
- CRNT N/A
- DERM N/A
- EPS Growth
- CRNT 367.84
- DERM N/A
- EPS
- CRNT 0.25
- DERM N/A
- Revenue
- CRNT $394,344,000.00
- DERM $56,243,000.00
- Revenue This Year
- CRNT $3.12
- DERM $28.99
- Revenue Next Year
- CRNT $7.89
- DERM $52.61
- P/E Ratio
- CRNT $9.86
- DERM N/A
- Revenue Growth
- CRNT 11.94
- DERM N/A
- 52 Week Low
- CRNT $1.95
- DERM $3.54
- 52 Week High
- CRNT $5.73
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- CRNT 59.42
- DERM 53.22
- Support Level
- CRNT $2.53
- DERM $6.78
- Resistance Level
- CRNT $2.49
- DERM $7.34
- Average True Range (ATR)
- CRNT 0.10
- DERM 0.35
- MACD
- CRNT 0.02
- DERM 0.03
- Stochastic Oscillator
- CRNT 83.72
- DERM 78.81
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.